Compare JBS N.V. Class A Common Shares (JBS) vs T-Rex 2X Inverse MSTR Daily Target ETF (MSTZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
JBS N.V. Class A Common Shares vs T-Rex 2X Inverse MSTR Daily Target ETF — how do they compare? JBS N.V. Class A Common Shares trades at $13.02 (market cap $13.96B), while T-Rex 2X Inverse MSTR Daily Target ETF trades at $3.19 (market cap $95.31M). The key difference: JBS N.V. Class A Common Shares is far larger — about 146.5× T-Rex 2X Inverse MSTR Daily Target ETF's market cap, and JBS N.V. Class A Common Shares pays a 10.31% dividend while T-Rex 2X Inverse MSTR Daily Target ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold JBS N.V. Class A Common Shares for 0 Days and T-Rex 2X Inverse MSTR Daily Target ETF for 8 Days on average.
| JBS | MSTZ | |
|---|---|---|
Market Cap | $13.96B | $95.31M |
Volume | 5,326,589 | 60,610,424 |
Sector | Consumer Staples | Leveraged / Inverse |
52-Week High | $18.42 | $27.92 |
52-Week Low | $10.86 | $2.29 |
Typical Hold Time | 0 Days | 8 Days |
Enterprise Value | $34.93B | — |
Dividend Yield | 10.31% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
JBS trades at $12.93, up 0.54% today, with a neutral technical signal and strong analyst buy consensus. The stock shows attractive valuation with a P/E of 12.08 and P/S of 0.47, though recent quarterly EPS misses and a declining profit margin to 1.22% in 2026 highlight earnings pressure. Recent news includes a proposal to acquire full control of Pilgrim's Pride and a joint venture in Southeast Asia, indicating strategic expansion.
The outlook is mixed: analyst targets suggest ~40% upside to $18.17, but risks include execution on acquisitions, margin compression, and volatile beef markets. Cash flow turned positive in 2026 projections, supporting growth initiatives, yet debt levels and competitive pressures warrant caution for investors seeking stability.
MSTZ trades at $2.69, up 0.37% today, with a bearish technical signal driven by moving averages. Key financial ratios like P/E and P/S are unavailable, limiting fundamental assessment. The stock faces resistance at $3, with support at $2. Recent ETF coverage highlighted leveraged fund performance but lacked direct MSTZ news.
Outlook is cautious due to missing financial data and bearish technicals. Risks include valuation opacity and market volatility. Investment appeal hinges on upcoming earnings clarity and institutional interest, with current sentiment neutral amid limited analyst coverage.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About JBS N.V. Class A Common Shares
JBS N.V. is a protein-processing company producing beef, pork, poultry, lamb, fish, and plant-based products, headquartered in São Paulo and Amsterdam. It operates more than 250 production facilities across over 16 countries under brands including Friboi, Seara, Swift, and Pilgrim's, and is the majority shareholder of Pilgrim's Pride Corporation.
Read more on JBS →About T-Rex 2X Inverse MSTR Daily Target ETF
MSTZ is a leveraged ETF that seeks daily investment results corresponding to 200% of the inverse (opposite) of the daily performance of the MicroStrategy Incorporated (MSTR) stock. It is designed as a tactical tool for experienced traders to take a bearish position on MSTR, a company known for its large Bitcoin holdings. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment, as its performance over longer periods may significantly deviate from its stated daily objective.
Read more on MSTZ →
